首页|期刊导航|Acta Biochimica et Biophysica Sinica|Targeting USP2 induces degradation of PML-RARαwith or without drug-resistant mutations in acute promyelocytic leukemia
Targeting USP2 induces degradation of PML-RARαwith or without drug-resistant mutations in acute promyelocytic leukemia
Jie Zhang Wenxuan Wu Yun Wang Youping Zhang Yingying Wang Wenhui Bai Zhenge Zhang Chujiao Zhu Yunzhao Wu Ziwei Zhang Li Yang Hu Lei Hanzhang Xu Li Zhou Yingli Wu
Acta Biochimica et Biophysica Sinica2026,Vol.58Issue(3):P.574-583,10.
Acta Biochimica et Biophysica Sinica2026,Vol.58Issue(3):P.574-583,10.DOI:10.3724/abbs.2025135
Targeting USP2 induces degradation of PML-RARαwith or without drug-resistant mutations in acute promyelocytic leukemia
摘要
关键词
acute promyelocytic leukemia/PML-RARα/USP2/ML364/drug resistance分类
医药卫生引用本文复制引用
Jie Zhang,Wenxuan Wu,Yun Wang,Youping Zhang,Yingying Wang,Wenhui Bai,Zhenge Zhang,Chujiao Zhu,Yunzhao Wu,Ziwei Zhang,Li Yang,Hu Lei,Hanzhang Xu,Li Zhou,Yingli Wu..Targeting USP2 induces degradation of PML-RARαwith or without drug-resistant mutations in acute promyelocytic leukemia[J].Acta Biochimica et Biophysica Sinica,2026,58(3):P.574-583,10.基金项目
supported by the grants from the National Natural Science Foundation of China(Nos.82470152,82170145,82170172) (Nos.82470152,82170145,82170172)
the CAMS Innovation Fund for Medical Sciences(No.2019-I2M-5-051) (No.2019-I2M-5-051)
the Shanghai Municipal Commission of Health and Family Planning(No.ZY(2021-2023)-0208) (No.ZY(2021-2023)
the China Postdoctoral Science Foundation(No.2024M762019). (No.2024M762019)